Copia Wealth Management
Source: SEC Form 13F · as of Mar 2026Copia Wealth Management holds 21 biotech & pharma companies tracked by BioSniper, totaling $647K in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$647K
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 878 | $145K |
| AMGNAMGEN INC | 302 | $106K |
| ABBVAbbVie Inc. | 348 | $76K |
| JNJJOHNSON & JOHNSON | 294 | $72K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 240 | $65K |
| CORCencora Inc. | 121 | $38K |
| DVADaVita Inc. | 202 | $31K |
| LLYELI LILLY & Co | 33 | $30K |
| ABTABBOTT LABORATORIES | 281 | $29K |
| NVSNovartis AG | 160 | $24K |
| MRKMerck & Co., Inc. | 111 | $13K |
| MCKMcKesson Corporation | 12 | $11K |
| PFEPFIZER INC | 165 | $5K |
| SRPTSarepta Therapeutics, Inc. | 22 | $479 |
| DGXQuest Diagnostics Incorporated | 2 | $392 |
| VTRSViatris Inc | 22 | $297 |
| OGIORGANIGRAM GLOBAL INC. | 142 | $190 |
| FLGTFulgent Genetics Inc. | 10 | $159 |
| REGNREGENERON PHARMACEUTICALS, INC. | 0 | $22 |
| ELVElevance Health Inc. | 0 | $19 |
| CGCCanopy Growth Corp | 10 | $9 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.